belcesiran
belcesiran: developed by 1 company · 1 clinical trial tracked.
belcesiran evidence translation
What we can confirm
1 tracked trial
What it means
What to watch
Prepared research question
How could belcesiran → DRNA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Dicerna Pharmaceuticals Inc (DRNA) | Phase 2 |
Clinical Trials (1)
A Phase 2, Randomized, Double-blind, Placebo-Controlled Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Dose Levels of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Primary endpoint: Number of Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)
Frequently asked questions
Who is developing belcesiran?
belcesiran is being developed by Dicerna Pharmaceuticals Inc.
How many clinical trials involve belcesiran?
BioSniper tracks 1 clinical trial involving belcesiran.